- Edgewise Therapeutics ( NASDAQ: EWTX ) has priced its upsized underwritten public offering of 11,627,907 shares of its common stock at a price of $10.32/share for an expected gross proceeds to be $120M.
- All of the shares are to be sold by Edgewise Therapeutics.
- Underwriters are granted a 30-day option to purchase up to an additional 1,744,186 shares of its common stock.
- Offering is expected to close on or about September 16, 2022.
- Earlier, Edgewise Therapeutics proposes $100M stock offering plan .
For further details see:
Edgewise Therapeutics prices upsized $120M stock offering